| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 32.85▲ | 32.85▲ | 32.85▲ | 32.79▲ | 32.77▲ |
| MA10 | 32.59▲ | 32.59▲ | 32.59▲ | 33.09▲ | 32.57▲ |
| MA20 | 32.41▲ | 32.41▲ | 32.41▲ | 32.99▲ | 32.78▲ |
| MA50 | 32.60▲ | 32.60▲ | 32.51▲ | 32.69▲ | 31.51▲ |
| MA100 | 31.61▲ | 31.61▲ | 31.55▲ | 32.69▲ | 30.58▲ |
| MA200 | 31.09▲ | 30.70▲ | 30.60▲ | 31.58▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.060▲ | 0.059▲ | 0.053▲ | -0.009▼ | -0.074▼ |
| RSI | 53.655▲ | 53.661▲ | 53.843▲ | 55.115▲ | 58.424▲ |
| STOCH | 73.783 | 73.783 | 73.783 | 43.744 | 50.840 |
| WILL %R | -31.544 | -31.544 | -31.544 | -31.561 | -30.790 |
| CCI | 84.774 | 84.774 | 84.774 | 55.244 | 15.221 |
|
Monday, November 02, 2026 04:14 PM
Travere Therapeutics (NASDAQ:TVTX) reported third-quarter results marked by record FILSPARI sales, continued early adoption in focal segmental glomerulosclerosis (FSGS), and progress across its kidney ...
|
|
Tuesday, August 04, 2026 05:00 PM
"The second quarter was exceptional." (President, CEO & Director Eric Dube) "This was the first quarter with FILSPARI commercially available across both IgA nephropathy and FSGS, and we are very ...
|
|
Thursday, April 09, 2026 04:10 AM
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 11/11/26 | 33.3094 | 33.3283 | 33.28 | 33.3283 | 925 |
| 10/11/26 | 32.85 | 32.9969 | 32.77 | 32.9969 | 76,980 |
| 09/11/26 | 32.61 | 33.03 | 32.61 | 33.008 | 1,100 |
| 06/11/26 | 32.2009 | 32.2009 | 32.2009 | 32.2009 | 133 |
| 05/11/26 | 32.64 | 32.64 | 32.36 | 32.4152 | 2,329 |
| 04/11/26 | 33.8482 | 33.8482 | 33.7741 | 33.7741 | 975 |
| 03/11/26 | 33.56 | 33.56 | 33.27 | 33.3363 | 2,023 |
| 02/11/26 | 33.41 | 33.41 | 33.3418 | 33.3418 | 300 |
| 30/10/26 | 33.19 | 33.19 | 33.044 | 33.044 | 527 |
| 29/10/26 | 33.5029 | 33.5029 | 33.5029 | 33.5029 | 179 |
|
|
||||
|
|
||||
|
|